All materials on this page that have
been written and produced by TAC may be reproduced and distributed at no
charge and without TAC's permission, so long as the original writers are
acknowledged. If you choose to modify the original documents, it must be
clearly indicated what your additions are and the original authors must
still be acknowledged. Please note, however, that some documents have not
been produced by TAC and this notice does not apply to them.
Mother-to-Child Transmission Prevention Pamphlet
Distributed in Cape Town
Nevirapine/AZT for Pregnant Women with HIV Now!
Only 40 in every 100 women with HIV will pass the virus on to their babies
during and after birth. This can be reduced by half with medicine. The
government can implement a Mother-to-Child-Transmission-Prevention (MTCTP)
programme that will prevent 2500 babies a month from contracting HIV. Children
with HIV get sick much more often and suffer tremendously. In that time,
their mother may also get ill and be denied proper healthcare. This must
What Medicines can be Used to Prevent Mother-to-Child-Transmission of HIV?
These are the different medicines available to reduce the risk of HIV transmission
from a mother to her child.
Scientific studies from around the world and Africa show that AZT reduces
the chance of a mother transmitting the virus to her child by half.
AZT is one of the oldest available treatments for HIV and all its side-effects
have been studied. A short course for prevention does not have any lasting
side-effects on mother or child.
Scientific evidence from Uganda and South Africa shows that NVP is cheaper
and easier to use than AZT, and it is as effective.
NVP has one disadvantage over AZT. Like AZT, it is one of the medicines
that can be used to treat all people with HIV. However, in some cases pregnant
mothers who take NVP for MTCTP may not be able to use it again. Some can
use it again after two years. This is called drug resistance. This limits
the treatment options available to the mother. However, there are alternatives.
Why must the Government Implement an MTCTP programme?
The Constitution says that the government has a duty to respect and preserve
human life. It also says that all women have a right to make choices about
bearing children. Crucially, the government has a duty to provide everyone
with access to health care within its budget.
Treating pregnant women with HIV with NVP or AZT will definitely reduce
the HIV infection rate in South Africa and save thousands of lives.
The majority of women and children affected are poor and black. To deny
them access to medication says that the lives of poor, black women are
cheap. This is immoral.
A University of Cape Town study has shown that preventing babies from getting
HIV is cheaper than the hospital and medical costs that would be incurred
if an MTCTP program is not implemented.
The state loses approximately R800m a year by failing to prevent HIV in
Implementing MTCTP will only cost the state approximately R80 million a
year, about 1% of the total health budget.
Implement an MTCTP Programme Now!
TAC demands that the government immediately implement a programme to prevent
mother-to-child-transmission of HIV.
This programme must be implemented in the five most affected provinces
at primary healthcare level.